Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Merle

Showing results (221-230 of 233) with videos related to

Pageof 24
Sort By:
Leukemia & Lymphoma|May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patientsC Soussain, B Souleau, J Gabarre, et al.
Leukemia|October 23, 2009
Aberrant telomere structure is characteristic of resistant chronic lymphocytic leukaemia cellsT Brugat, N Gault, I Baccelli, et al.
Leukemia|November 21, 1998
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemiaL Sutton, K Maloum, H Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2009
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West IndiesJ A Cabrera-Gómez, M Bonnan, A González-Quevedo, et al.
Leukemia|August 21, 2013
Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletionM Le Garff-Tavernier, L Herbi, C de Romeuf, et al.
Leukemia & Lymphoma|November 8, 2001
A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive formsC Hercher, M Robain, F Davi, et al.
Leukemia|October 27, 2010
Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodiesM Le Garff-Tavernier, J Decocq, C de Romeuf, et al.
Journal of Biological Regulators and Homeostatic Agents|March 25, 2005
Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathiesM Pérez-Andrés, M Santiago, J Almeida, et al.
Journal Francais D'Ophtalmologie|November 25, 2010
[Study and prevention of contact lens-related microbial keratitis with a standardized questionnaire]A Sauer, F Abry, J-P Berrod, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Pageof 24

Showing results (221-230 of 233) with videos related to

Sort By:
Pageof 24
Leukemia & Lymphoma|May 26, 1999
Intensive chemotherapy with hematopoietic cell transplantation after ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma. Results of a single-centre study of 65 patientsC Soussain, B Souleau, J Gabarre, et al.
Leukemia|October 23, 2009
Aberrant telomere structure is characteristic of resistant chronic lymphocytic leukaemia cellsT Brugat, N Gault, I Baccelli, et al.
Leukemia|November 21, 1998
Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemiaL Sutton, K Maloum, H Gonzalez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2009
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West IndiesJ A Cabrera-Gómez, M Bonnan, A González-Quevedo, et al.
Leukemia|August 21, 2013
Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletionM Le Garff-Tavernier, L Herbi, C de Romeuf, et al.
Leukemia & Lymphoma|November 8, 2001
A multicentric study of 41 cases of B-prolymphocytic leukemia: two evolutive formsC Hercher, M Robain, F Davi, et al.
Leukemia|October 27, 2010
Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodiesM Le Garff-Tavernier, J Decocq, C de Romeuf, et al.
Journal of Biological Regulators and Homeostatic Agents|March 25, 2005
Immunophenotypic approach to the identification and characterization of clonal plasma cells from patients with monoclonal gammopathiesM Pérez-Andrés, M Santiago, J Almeida, et al.
Journal Francais D'Ophtalmologie|November 25, 2010
[Study and prevention of contact lens-related microbial keratitis with a standardized questionnaire]A Sauer, F Abry, J-P Berrod, et al.
Leukemia|May 2, 2008
The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemiaE Chapiro, I Radford-Weiss, C Bastard, et al.
Pageof 24